286 related articles for article (PubMed ID: 2144016)
1. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
Putnak JR; Schlesinger JJ
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
[TBL] [Abstract][Full Text] [Related]
2. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice.
Desprès P; Dietrich J; Girard M; Bouloy M
J Gen Virol; 1991 Nov; 72 ( Pt 11)():2811-6. PubMed ID: 1834798
[TBL] [Abstract][Full Text] [Related]
3. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
4. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E
Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531
[TBL] [Abstract][Full Text] [Related]
5. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.
Falgout B; Bray M; Schlesinger JJ; Lai CJ
J Virol; 1990 Sep; 64(9):4356-63. PubMed ID: 2143542
[TBL] [Abstract][Full Text] [Related]
6. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
[TBL] [Abstract][Full Text] [Related]
7. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment.
Cane PA; Gould EA
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1241-6. PubMed ID: 3133449
[TBL] [Abstract][Full Text] [Related]
8. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
9. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
[TBL] [Abstract][Full Text] [Related]
10. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
[TBL] [Abstract][Full Text] [Related]
11. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
Schlesinger JJ; Brandriss MW; Walsh EE
J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
[TBL] [Abstract][Full Text] [Related]
12. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
Schlesinger JJ; Foltzer M; Chapman S
Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
[TBL] [Abstract][Full Text] [Related]
13. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody.
Schlesinger JJ; Brandriss MW; Putnak JR; Walsh EE
J Gen Virol; 1990 Mar; 71 ( Pt 3)():593-9. PubMed ID: 2138210
[TBL] [Abstract][Full Text] [Related]
14. Characterization of yellow fever virus proteins E and NS1 expressed in Vero and Spodoptera frugiperda cells.
Desprès P; Girard M; Bouloy M
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1331-42. PubMed ID: 1710649
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
Brandriss MW; Schlesinger JJ; Walsh EE
J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
[TBL] [Abstract][Full Text] [Related]
16. 17D yellow fever vaccine virus envelope protein expressed by recombinant baculovirus is antigenically indistinguishable from authentic viral protein.
Shiu SY; Morikawa S; Buckley A; Higgs S; Karunakarannair V; Blachere C; Gould EA
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1451-4. PubMed ID: 1710651
[TBL] [Abstract][Full Text] [Related]
17. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever.
Schäfer B; Holzer GW; Joachimsthaler A; Coulibaly S; Schwendinger M; Crowe BA; Kreil TR; Barrett PN; Falkner FG
PLoS One; 2011; 6(9):e24505. PubMed ID: 21931732
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ
J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058
[TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.
Co MD; Terajima M; Cruz J; Ennis FA; Rothman AL
Virology; 2002 Feb; 293(1):151-63. PubMed ID: 11853408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
